Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Blood
|
May 15, 1989
Factors influencing the acceleration of human factor XIa inactivation by antithrombin III
C F Scott, R W Colman
Blood
|
October 1, 1982
Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III
C F Scott, M Schapira, R W Colman
Blood
|
March 1, 1986
Role of arginine residues in the coagulant activity of high molecular weight kininogen
J J Chang, C F Scott, R W Colman
Blood
|
July 10, 1998
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters
C F Scott, H Brandwein, J Whitbread, et al.
Blood
|
April 1, 1982
New and rapid functional assay for C1 inhibitor in human plasma
M Schapira, L D Silver, C F Scott, et al.
Blood
|
May 1, 1987
Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases
C F Scott, H R Wenzel, H R Tschesche, et al.
Blood
|
March 1, 1981
Effect of surfaces on fluid-phase prekallikrein activation
C F Scott, E P Kirby, P K Schick, et al.
Blood
|
January 1, 1984
Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay
C F Scott, D Sinha, F S Seaman, et al.
Blood
|
April 1, 1988
Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems
J L Brash, C F Scott, P ten Hove, et al.
Blood
|
May 29, 2000
Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding
W Zhang, R W Colman
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Blood
|
May 15, 1989
Factors influencing the acceleration of human factor XIa inactivation by antithrombin III
C F Scott, R W Colman
Blood
|
October 1, 1982
Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III
C F Scott, M Schapira, R W Colman
Blood
|
March 1, 1986
Role of arginine residues in the coagulant activity of high molecular weight kininogen
J J Chang, C F Scott, R W Colman
Blood
|
July 10, 1998
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters
C F Scott, H Brandwein, J Whitbread, et al.
Blood
|
April 1, 1982
New and rapid functional assay for C1 inhibitor in human plasma
M Schapira, L D Silver, C F Scott, et al.
Blood
|
May 1, 1987
Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases
C F Scott, H R Wenzel, H R Tschesche, et al.
Blood
|
March 1, 1981
Effect of surfaces on fluid-phase prekallikrein activation
C F Scott, E P Kirby, P K Schick, et al.
Blood
|
January 1, 1984
Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay
C F Scott, D Sinha, F S Seaman, et al.
Blood
|
April 1, 1988
Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems
J L Brash, C F Scott, P ten Hove, et al.
Blood
|
May 29, 2000
Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding
W Zhang, R W Colman
Page
of 5